4
Changes in Ownership
Harmony Biosciences Holdings, Inc. Filed Acc 0001615993-25-000005
PRESIDENT, CEO sold 25,933 shares at $40.11 ($1,040,103)
- PRESIDENT, CEO acquired 20,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Dayno Jeffrey M. · PRESIDENT, CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-12 | Exercise or conversion : show line 1 in the form 10b5-1 | +20,000 | $8.22 | $164,400 | 20,000 | D |
| 2025-12-12 | Sale : show line 2 in the form 10b5-1 | −20,000 | $40.11 | $802,146 | 0 | D |
| 2025-12-12 | Sale : show line 3 in the form 10b5-1 | −5,933 | $40.11 | $237,957 | 0 | D |
| Open-market sales · 25,933 sh · avg $40.11 · $1,040,103 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-12 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option | −20,000 | 0 | D |
Loading xslF345X05/form4-12172025_051201.xml…